Magic mushroom compound probes brain in FND patients
NCT ID NCT05723276
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a single dose of psilocybin, the active ingredient in magic mushrooms, affects brain networks in 24 adults with functional neurological disorder (FND). Participants receive the drug with therapeutic support, and brain scans are taken before and after to see if a key network called the default mode network changes. The goal is to understand brain function in FND, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNCTIONAL NEUROLOGICAL DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
South London and Maudsley NHS Foundation Trust
London, United Kingdom